Contribution of prediabetes to the occurrence of CKD
| Phenotypes | Range | N | CKD, n (%) | ARP (%) | PARP (%) | |
| ADA | NGT | 1836 | 10 (0.54) | |||
| Criteria | Prediabetes | 4610 | 78 (1.69) | 68.0 | 60.6 | |
| IFG | 5.6–6.9 mmol/L | 1954 | 38 (1.94) | 72.2 | ||
| 5.6–6.0 mmol/L | 1352 | 23 (1.70) | 68.2 | |||
| 6.1–6.9 mmol/L | 602 | 15 (2.49) | 78.3 | |||
| IGT | 7.8–11.0 mmol/L | 1696 | 36 (2.12) | 74.5 | ||
| EHbA1c | 5.7%–6.4% | 3848 | 65 (1.69) | 68.0 | ||
| 5.7%–5.9% | 2074 | 29 (1.40) | 61.4 | |||
| 6.0%–6.4% | 1774 | 36 (2.03) | 73.4 | |||
| WHO | NGT | 3507 | 34 (0.97) | |||
| Criteria | Prediabetes | 2939 | 54 (1.84) | 47.3 | 29.2 | |
| IFG | 6.1–6.9 mmol/L | 602 | 15 (2.49) | 61.0 | ||
| IGT | 7.8–11.0 mmol/L | 1696 | 36 (2.12) | 54.2 |
ADA, American Diabetes Association; ARP, attributable risk per cent; CKD, chronic kidney disease; EHbA1c, elevated glycated hemoglobin A1c; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; NGT, normal glucose tolerance; PARP, population attributable risk per cent.